Evidence map›Paper›PMID 39420075›Full record

ArticleCommunications biology2024

Intelligent guide RNA: dual toehold switches for modulating luciferase in the presence of trigger RNA.

Mohammad Hashemabadi, Hossein Ali Sasan, Saman Hosseinkhani, Mojdeh Amandadi, Azadeh Samareh Gholami, Majid Sadeghizadeh

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammad HashemabadiDepartment of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.ORCID 0000-0001-7024-9512
Hossein Ali SasanDepartment of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran.ORCID 0000-0002-5752-293X
Saman HosseinkhaniDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. Saman_H@modares.ac.ir.ORCID 0000-0002-0345-7909
Mojdeh AmandadiDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Azadeh Samareh GholamiDepartment of Genetics, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Majid SadeghizadehDepartment of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. Sadeghma@modares.ac.ir.ORCID 0000-0002-2497-3152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CRISPR system finds extensive application in molecular biology, but its continuous activity can yield adverse effects. Leveraging programmable CRISPR/Cas9 function via nano-device mediation effectively mitigates these drawbacks. The integration of RNA-sensing platforms into CRISPR thus empowers it as a potent tool for processing internal cell data and modulating gene activity. Here, an intelligent guide RNA-a cis-repressed gRNA synthetic circuit enabling efficient recognition of specific trigger RNAs-is developed. This platform carries two toehold switches and includes an inhibited CrRNA sequence. In this system, the presence of cognate trigger RNA promotes precise binding to the first toehold site, initiating a cascade that releases CrRNA to target a reporter gene (luciferase) in this study. Decoupling the CrRNA segment from the trigger RNA enhances the potential of this genetic logic circuit to respond to specific cellular circumstances, offering promise as a synthetic biology platform.

Indexed as

CRISPR-Cas SystemsLuciferasesRNA, Guide, CRISPR-Cas SystemsGenes, ReporterHumansSynthetic BiologyLuciferasesRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID39420075
PMCPMC11487279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.